Hill Sarah, Duffill Mark, Lamont Duncan, Rademaker Marius, Yung Anthony
Department of Dermatology, Waikato Hospital, Hamilton, New Zealand.
Australas J Dermatol. 2007 Nov;48(4):239-41. doi: 10.1111/j.1440-0960.2007.00395.x.
A 57-year-old man is presented with blue pseudochromhidrosis affecting the face and neck following combination treatment with lansoprazole, a proton pump inhibitor, and ranitidine, a type two histamine receptor antagonist. The diagnosis was made on the basis of clinico-histological features and growth of Malassezia furfur, and Bacillus species, not Bacillus cereus, in the absence of lipofuscin. The pseudochromhidrosis resolved on stopping both medications and did not recur on restarting only the proton pump inhibitor.
一名57岁男性在联合使用质子泵抑制剂兰索拉唑和2型组胺受体拮抗剂雷尼替丁后，出现累及面部和颈部的蓝色假性色汗症。根据临床组织学特征以及糠秕马拉色菌和非蜡样芽孢杆菌的生长情况（无脂褐素）做出诊断。停用两种药物后假性色汗症消失，仅重新使用质子泵抑制剂时未复发。
